Zevra Therapeutics, Inc. Long-term Line of Credit
Zevra Therapeutics, Inc. (ZVRA) had Long-term Line of Credit of $50.00 thousand as of 2015-09-30, per its 10-Q filed 2015-11-13.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2015-11-13
- 2015-09-30: Long-term Line of Credit $50.00K.
- 2015-06-30: Long-term Line of Credit $50.00K.
- 2015-03-31: Long-term Line of Credit $50.00K.
- 2014-12-31: Long-term Line of Credit $50.00K.
| Period end | Long-term Line of Credit |
|---|---|
| 2015-09-30 | $50.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $50.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $50.00K 10-Q · filed 2015-05-29 |
| 2014-12-31 | $50.00K 10-Q · filed 2015-11-13 |
| 2014-06-30 | $50.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |